Agitation in head injury. II. Treatment with antidepressant, sympathomimetic, beta blocker, dopaminergic and other drugs;Agitacion en el traumatismo craneoencefalico. II. Tratamiento con antidepresivos, simpaticomimeticos, betabloqueantes, dopaminergicos y otros farmacos

Revista de Neurologia

Volumn 30, Issue 11, 2000, Pages 1044-1047

  Bascunana H ^a,b   Villarreal, I ^a   Alfonso, S ^a   Terre R ^a   Bernabeu, M ^a  

^a University Institute affiliated with the Autonomous University of Barcelona   (Spain)

^b Institut Guttmann   (Spain)

Author keywords

Agitation; Antidepressants; Beta blockers; Dopaminergic drugs; Sympathomimetic drugs; Traumatic head injury

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; DOPAMINE RECEPTOR STIMULATING AGENT; LITHIUM; MEDROXYPROGESTERONE; PLACEBO; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGGRESSIVENESS; AGITATION; CLINICAL TRIAL; COMA; DELIRIUM; DRUG MECHANISM; HEAD INJURY; HEART VENTRICLE ARRHYTHMIA; HUMAN; INSOMNIA; MENTAL DISEASE; MIGRAINE; REVIEW; STUPOR; SYNCOPE; VISUAL DISORDER; BRAIN INJURY; RESTLESSNESS;

ADRENERGIC BETA-ANTAGONISTS; ANTIDEPRESSIVE AGENTS; BRAIN INJURIES; DOPAMINE AGONISTS; HUMANS; PSYCHOMOTOR AGITATION; SYMPATHOMIMETICS;

EID: 0034200680     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3011.99480     Document Type: Review

References (39)

1. Wade SL, Taylor HG, Drotar D. Childhood traumatic brain injury: initial impact on the family. J Learn Disabil 1996; 29: 652-61.
2. Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology. Oxford: Oxford University Press; 1996.
3. Kaplan HI, Sadock BJ. Pocket handbook of psychiatric drug treatment. Baltimore: Williams & Williams; 1993.
4. Jackson RD, Corrigan JD, Gribble MW. Amitriptyline for agitation in head injury. Arch Phys Med Rehabil 1985; 66: 180-1.
5. Mysiw WJ, Jackson RD. Tricyclic antidepressant therapy after traumatic brain injury. J Head Trauma Rehabil 1987; 2: 34-42.
6. Szlabowicz JW, Stewart JT. Amitriptyline treatment of agitation associated with anoxic encephalopathy. Arch Phys Med Rehabil 1990; 71: 612-3.
7. Horn LJ, Zasler ND. Medical rehabilitation of traumatic brain injury. St. Louis: Mosby; 1996.
8. Silver BV, Yablon SA. Akatisia resulting from traumatic brain injury. Brain Inj 1996; 8: 609-14.
9. Wroblewski BA, McColgan K, Smith K. The incidence of seizures during tricyclic antidepressant drug treatment in a brain injury population. J Clin Psicopharmacol 1990; 10: 124-8.
10. Wiercisiewski DR, McDeavitt JT. Drugs for management of acute and chronic behavioral disorders. Phys Med Rehabil Clin North Am 1997; 8: 763-80.
11. Sky AJ, Grossberg GT. The use of psychotropic medication in the management of problem behaviors in the patient with Alzheimer's disease. Med Clin North Am 1994; 78: 811-22.
12. Mysiw WH, Sandel ME. The agitated brain injury patient. Part II. Pathophysiology and treatment. Arch Phys Med Rehabil 1997; 78: 213-20.
13. Markowitz PI. Effect of fluoxetine on self-injurious behavior in the developmentally disabled: a preliminary study. J Clin Psychopharmacol 1992; 12: 27-31.
14. Ricketts R. Fluoxetine treatment of severe self-injury in young adults with mental retardation. J Am Acad Child Adolesc Psychiatry 1993; 32: 865-9.
15. Seliger GM, Homstein A, Flax J. Fluoxetine improves emotional incontinence. Brain Inj 1992; 6: 267-70.
16. Sloan RL, Brown KW, Pentland B. Fluoxetine as a treatment for emotional lability after brain injury. Brain Inj 1992; 6: 315-9.
17. Johnson JA, Lineberry CG, Ascher JA. A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry 1991; 52: 450-6.
18. Reynols JEF. Martindale: the extra pharmacopoeia. London: The Pharmaceutical Press; 1993.
19. Glenn MB, Joseph AB. The use of lithium for behavioral and affective disorders after traumatic brain injury. J Head Trauma Rehabil 1987; 2: 68-76.
20. Shakla S, Cook BL, Mukherjee S. Mania following head trauma. Am J Psychiatry 1987; 144: 93-6.
21. Glenn MB, Wroblewski P, Parziale J, Levine L, Whyte J, Rosenthal M. Lithium carbonate for aggressive behavior of affective instability in ten brain injury patients. Am J Phys Med Rehabil 1989; 68: 221-6.
22. Kraus M, Burch EA. Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review. South Med J 1992; 85: 985-91.
23. Evans RW, Gualtieri CT, Hicks RE. Aneuropathic substrate for stimulant drug effects in hyperactive children. Clin Neuropharmacol 1986; 9: 264-81.
24. Mooney GF, Haas LJ. Effect of methylphenidate on brain injury-related anger. Arch Phys Med Rehabil 1993; 74: 153-60.
25. Ratey JJ. Use of propranolol for provoked an unprovoked episodes of rage. Am J Psychiatry 1983; 140: 1356-7.
26. Yudofsky SC. Propranolol in the treatment of rage and violent behavior in patients with chronic brain syndromes. Am J Psychiatry 1981; 138: 218-20.
27. Stroudemire A. Epidemiology and psychopharmacology of anxiety in medical patients. J Clin Psychiatry 1996; 57: 64-73.
28. Brooke MM, Patterson DR, Questad KA, Cárdenas D, Farrel-Roberts L. The treatment of agitation during initial hospitalization after traumatic brain injury. Arch Phys Med Rehabil 1992; 73: 917-21.
29. Mattes JA. Metoprolol for intermittent explosive disorder. Am J Psychiatry 1985; 142: 1108-9.
30. Sitland-Marken PA, Wells BG, Froemming JH. Psychiatric applications of bromocriptine therapy. J Clin Psychiatry 1990; 51: 68-82.
31. Kornhuber J, Weller M, Schoppmeyer K, Riederer P. Amantadine and memantadina are NMDA receptor antagonists with neuroprotective properties. J Neural Transm 1994; 43 (Suppl): S91-104.
32. Cohen RA, Fisher M. Amantadine treatment of fatigue associated with multiple sclerosis. Arch Neurol 1988; 45: 1104-6.
33. Moryl E, Danysz W, Quack G. Pontential antidepressive properties of amantadine, nemantine and bifemelane. Pharmacol Toxicol 1993; 72: 394-7.
34. Imamura T, Suzuki K, Yamadori A, Sahara M, Nagasawa H, Itah M. Improved perseveration with amantadine. Brain Nerve 1994; 46: 556-62.
35. Nickels JL, Schneider WN, Dombovy ML, Wong TM. Clinical use of amantadine in brain injury rehabilitation. Brain Inj 1994; 8: 709-18.
36. Chandler M, Barnhill J, Gualtieri T. Amantadine for the agitated head-injured patient. Brain Inj 1988; 2: 309.
37. Childs A. Naltrexone in organic bulimia: a preliminary report. Brain Inj 1987; 1: 49-55.
38. Sachdev P, Smith J, Matheson J. Amygdalo-hippocampectomy for pathological aggression. Aust N Z J Psychiatry 1992; 26: 671.
39. Fugate LP, Spacek LA, Kresty LA, Levy CE, Johnson JC, Mysiw WJ. Measurement and treatment of agitation following traumatic brain injury: II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation. Arch Phys Med Rehabil 1997; 78: 924-9.